# Kalaris Therapeutics, Inc.: Form 8-K, filed Aug 11, 2026

- Company: [Kalaris Therapeutics, Inc.](/companies/klrs.md) (CIK 1754068)
- Form: 8-K
- Filed: 2026-08-11
- Accepted by EDGAR: Aug 11, 2026, 08:05 ET
- Period: 2026-08-11
- Accession: 0001193125-26-343477
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1754068/000119312526343477/d114296d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1754068/000119312526343477/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1754068/000119312526343477/d114296d8k.htm

Filed Aug 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-343477. Last ingested by Listed: Nov 11, 2026, 00:15 ET. No prices; not investment advice.